Havens Advisors’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Havens Advisors’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,000	Closed	-$119K	–	48
2016 Q3	$119K	Buy	+3,000	New	+$33.5K	0.09%	33

Havens Advisors's TBRA Position: Q4 2016 in Review

Havens Advisors sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 3,000 shares — an estimated $119K sold.

Havens Advisors first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $119K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Havens Advisors reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Havens Advisors sold 3,000 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $119K.
Havens Advisors first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Havens Advisors's Tobira Therapeutics, Inc. Common Stock position peaked at $119K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Havens Advisors's 13F filing for Q4 2016, filed 10 Jan 2017.